Evidence map›Paper›PMID 41382087›Full record

ArticleImplementation science : IS2025

What scientific inferences can be made with randomized implementation rollout trials.

C Hendricks Brown, J D Smith, Tamara Haegerich, Gregory Simon, Ian Cero, Gregory Aarons, Guillermo Prado, Peter Wyman, John Kane, Delbert Robinson and 8 more

Abstract read
In one paragraph

Article in Implementation science : IS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

C Hendricks BrownFeinberg School of Medicine, Northwestern University, Chicago, USA. hendricks.brown@northwestern.edu.ORCID 0000-0002-0294-2419
J D SmithUniversity of Utah, Salt Lake City, USA.
Tamara HaegerichNational Institute On Drug Abuse, North Bethesda, USA.
Gregory SimonKaiser Permanente Washington Health Research Institute, Seattle, USA.
Ian CeroUniversity of Rochester, Rochester, USA.
Gregory AaronsUniversity of California San Diego, San Diego, USA.
Guillermo PradoUniversity of Miami, Miami, USA.
Peter WymanUniversity of Rochester, Rochester, USA.
John KaneNorthwell Health, New York, USA.
Delbert RobinsonNorthwell Health, New York, USA.
Theresa L WalunasFeinberg School of Medicine, Northwestern University, Chicago, USA.
Lindsey ZimmermanStanford Veterans Administration, Palo Alto, USA.
Wouter VermeerFeinberg School of Medicine, Northwestern University, Chicago, USA.
Lia Chin-PurcellStanford University, Stanford, USA.
Moira McNultyUniversity of Chicago, Chicago, USA.
Katerina A ChristopoulosUniversity of California San Francisco, San Francisco, USA.
Bryan GarnerOhio State College of Medicine, Columbus, USA.
Mark McGovernStanford University, Stanford, USA.

Funding

NUCATS CTSA UM1 at Northwestern UniversityUM1TR005121 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sara Becker, Richard D'Aquila · 2024 to 2026
$23.4M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Use of topic modeling and stakeholderengagement to map determinants of implementation disparities in addiction and pain researchU2CDA057717 · NIDA · STANFORD UNIVERSITY · PI C. HENDRICKS BROWN · 2022 to 2026
$19.1M
Transforming health equity rhetoric to rigor: Development and validation of a novel measure assessing health equity in implementation of health interventionsP50DA054072 · NIDA · STANFORD UNIVERSITY · PI Mark P McGovern · 2022 to 2026
$18.1M
INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
Talking Early About Mental Health for AccessP50MH132502 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JUSTIN D SMITH, LAUREN S WAKSCHLAG · 2024 to 2026
$9.4M
Resource CoreP30AR072579 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Leena Sharma · 2017 to 2026
$8.3M
Effectiveness Trial of Wingman-Connect Implemented Across Career PhasesR01MH131738 · NIMH · UNIVERSITY OF ROCHESTER · PI Peter A Wyman · 2023 to 2026
$6.0M
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)R01DA052975 · NIDA · STANFORD UNIVERSITY · PI FORD, JAMES H, MCGOVERN, MARK P · 2021 to 2025
$3.3M
Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community ClinicsR01MH140440 · NIMH · UNIVERSITY OF CHICAGO · PI Katerina A Christopoulos, Moira McNulty · 2025 to 2026
$3.1M
Scaling a Parenting EBI for Latinx Youth Mental Health in Primary CareR01MH124718 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI BROWN, C. HENDRICKS, PRADO, GUILLERMO · 2021 to 2024
$3.0M
Participatory System Dynamics vs Audit and Feedback: A Cluster Randomized Trial of Mechanisms of Implementation Change to Expand Reach of Evidence-based Addiction and Mental Health CareR01DA046651 · NIDA · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI ZIMMERMAN, LINDSEY EILEEN · 2019 to 2023
$2.9M
AHRQ HHS U18HS027953HSRD VA I01 HX002521NCATS NIH HHS UM1 TR004409NCATS NIH HHS UM1 TR005121NCATS NIH HHS UM1TR005121NIAMS NIH HHS P30 AR072579NIAMS NIH HHS P30AR072579NIDA NIH HHS P30 DA027828NIDA NIH HHS P30DA027828NIDA NIH HHS P50 DA054072NIDA NIH HHS P50DA054072NIDA NIH HHS R01 DA046651NIDA NIH HHS R01DA046651NIDA NIH HHS R01 DA052975NIDA NIH HHS U2C DA057717NIDA NIH HHS U2CDA057717NIMH NIH HHS P50 MH132502NIMH NIH HHS P50MH132502NIMH NIH HHS R01 MH124718NIMH NIH HHS R01MH124718NIMH NIH HHS R01 MH131738NIMH NIH HHS R01MH131738NIMH NIH HHS R01 MH140440NIMH NIH HHS R01MH140440U.S. Department of Veterans Affairs I01HX002521
6 · The paper itself

Abstract

backgroundRandomized rollout trial designs, including stepped wedge designs, are commonly used to examine how well an evidence-based intervention or package is being implemented in community or healthcare settings. The multitude of implementation research questions and specific hypotheses suggest the need for diverse randomized rollout implementation trial designs, assignment principles and procedureds, and statistical modeling.

methodsWe separate key research questions and identify mixed effect models for randomized implementation rollout trials involving 1) a single implementation strategy that tests how this strategy varies over time and/or resources that are allocated, 2) comparison of two distinct implementation strategies, and 3) three distinct strategies or components tested in a single trial. Appropriate rollout designs, optimal assignment methods, and other design and analysis considerations are discussed for trials of up to three distinct implementation strategies.

resultsTo examine improvement in implementation outcomes we present a Fixed-Length Staggered Rollout Trial Design to examine how well a sustainment period continues to produce outcomes, The Rollout Implementation Optimization (ROIO) methodology illustrates testing for quality improvement. For comparing an existing to new strategy, we focus on a Stepped Wedge design, and for comparing two new strategies we describe a Head-to-Head Rollout trial design. To test for synergy between two components, we introduce a Head-to-Head Rollout trial design, and for testing an existing strategy to a new one followed by a sustainment period, we recommend using a Three-Phase Sequential Rollout Implementation trial design. Modeling choices are described, including options for specifying random effects that capture variations in site and clustering. We discuss comparisons of superiority versus non-inferiority testing and multiple contrasts. To support uses of these six designs and analyses, we provide computational code.

conclusionsThe large class of randomized rollout implementation trial designs provides rich opportunities to address research questions posed by implementation scientists. Balance in assigning sites to cohorts is important before random assignment to time of transition to a new implementation occurs. Specific hypotheses are tested with mixed effects models where fixed effects include comparisons of implementation conditions and random effects that account for variation in sites and clustering.

Indexed as

Implementation ScienceRandomized Controlled Trials as TopicResearch DesignHumansHead-to-head rollout trialMixed effect modelsNon-inferiority testingRandomized implementation rollout trial designRollout designsSequential rollout designStepped wedge trial designSustainment

Identifiers

PMID41382087
PMCPMC12831406

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.